Circulating methylated promoters of HK2 and EGFR as biomarkers in the early detection of cancer
Introduction Aberrant methylation of promoter DNA regions is a well-known epigenetic hallmark of cancer. Previous studies on tumorigenic mouse models revealed that abnormal methylation in the promoter regions of selected genes occurs during the early stages of tumorigenesis. To explore further changes in the blood circ...